Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Autor:
Wei Xu, Arnavaz Danesh, Rene Quevedo, Trevor J. Pugh, Mark Dowar, Amit M. Oza, Julia V. Burnier, Derek L. Clouthier, Jeff Bruce, Stephanie Lheureux, Youstina Hanna, Patricia Shaw, S. Y. Cindy Yang, Tiantian Li, Blaise A. Clarke, Pamela S. Ohashi, Lin Lu, Katherine Karakasis
Publikováno v:
Genome Medicine, Vol 10, Iss 1, Pp 1-17 (2018)
Genome Medicine
Genome Medicine
Background Patients diagnosed with high-grade serous ovarian cancer (HGSOC) who received initial debulking surgery followed by platinum-based chemotherapy can experience highly variable clinical responses. A small percentage of women experience excep
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-3 (2019)
Genome Medicine
Genome Medicine
Malignant peritoneal mesothelioma (PeM) is a rare and fatal cancer that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is limited to cytoreductive surgery and/or chemotherapy, and no effective targeted therapies for P